BWBei Wei

Bei Wei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bei Wei has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Space-map: 3D single-cell atlas reconstruction from serial sections

    by Rongduo Han, Cihan Ruan, Bingqing Zhao, Yuqi Tan, Emma Monte, Bei Wei, Joanna Bi, Thomas V. Karathanos, Rozelle Laquindanum, Gregory W. Charville, et al.

    High-resolution three-dimensional (3D) tissue atlases promise to link cellular architecture to tissue function, but assembling them from serial sections containing millions of cells remains challenging. Here we present Space-map, an accurate and efficient method for reconstructing 3D tissue models from high-content spatial molecular profiles. Space-map combines multiscale feature matching with large deformation diffeomorphic metric mapping to automate global alignment across serial sections while preserving local microanatomy. We generate spatial transcriptomics (Xenium; ~2.7 million cells) and proteomics (CODEX; ~4.8 million cells) datasets from serial sections to build 3D models of a colon polyp and healthy intestinal tissues. These models reveal cell-type heterogeneity in the polyp and preserved crypt and glandular architecture and mucosal-cavity continuity in healthy intestines. Benchmarking on our own and publicly available datasets demonstrates that Space-map achieves substantially higher registration accuracy and up to a tenfold speedup over existing methods, supporting its use as a robust framework for constructing 3D human tissue atlases at single-cell resolution.

  • Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy

    by Jingying Huang, Yahui Chen, Peng Deng, Qian Kong, Konglan Lin, Yan Li, Yiye Li, Changying Fu, Wen Deng, Jiannan Xv, et al.

    Tertiary lymphoid structures (TLSs) are associated with the efficacy of various oncological therapies. However, the comprehensive spatial TLS pharmacodynamics are largely unclear. Here, we performed multifaceted spatial transcriptomic analysis with whole-transcriptome coverage and single-cell resolution, complemented by the high-throughput spatial proteomics, to thoroughly characterize TLSs in clinical breast cancer samples after neoadjuvant therapy. Notably, spatial multi-omics data identified that precursors of exhausted T cells (Tpex cells) preferentially reside within TLSs. Spatial transcriptomics with TCR-seq revealed the presence of tumor-specific Tpex cells inside TLSs and their clonally related terminally differentiated effector T cells outside TLSs. B cells are nearest neighbors of Tpex cells in TLSs and B cells promote invigoration of Tpex cells via ICOSL-ICOS and CD86-CD28 interactions within TLSs. These findings extend the current understanding of TLS spatial architecture and highlight a therapy-induced evolution of anti-tumor immune responses driven by the interaction between Tpex cells and B cells within TLSs.


  • Open Access

    Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma

    by Yaqin Wu, Bei Wei, Zhentong Wei, Hongyan Wang, Yunyun Liu, Dongdong Xu, Xiaokang Li, Liyuan Guo, Huaiwu Lu, Huiling Shang

    Cervical cancer (CC), a leading cause of cancer-related deaths among women worldwide, is primarily driven by high-risk human papillomavirus (HPV) infections and comprises two major histological subtypes: adenocarcinoma (AC) and squamous cell carcinoma (SCC). Despite advances in prevention and treatment, the molecular and cellular heterogeneity of these subtypes poses significant challenges to achieving optimal clinical outcomes. Here, we integrate single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to dissect the cellular and spatial heterogeneity of AC and SCC, uncovering distinct tumor microenvironment (TME) dynamics that underlie their divergent clinical behaviors. Our scRNA-seq analysis reveals that AC is enriched in epithelial cells, while SCC exhibits a more immunogenic TME with elevated plasma cells and NK/T cells. Spatial transcriptomics further highlights robust interactions between CD8 + T cells and epithelial subtypes in SCC, contrasting with the stromal-rich, immune-cold phenotype of AC. We identify subtype-specific immune and stromal features, including ICOS+ Tregs, IDO1+ cancer-associated fibroblasts (CAFs), and PLVAP+ endothelial cells, which may drive immune evasion, angiogenesis, and metastasis. These findings provide a comprehensive framework for understanding CC heterogeneity and offer actionable insights for developing subtype-specific therapeutic strategies, such as combining immune checkpoint inhibitors with stromal-targeting agents. This study underscores the potential of spatial multi-omics technologies to advance precision oncology and improve outcomes for cervical cancer patients.


  • Open Access

    Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19

    by Aaron J. Wilk, Madeline J. Lee, Bei Wei, Benjamin Parks, Ruoxi Pi, Giovanny J. Martínez-Colón, Thanmayi Ranganath, Nancy Q. Zhao, Shalina Taylor, Winston Becker, et al.

    Our understanding of protective versus pathological immune responses to SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is limited by inadequate profiling of patients at the extremes of the disease severity spectrum. Here, we performed multi-omic single-cell immune profiling of 64 COVID-19 patients across the full range of disease severity, from outpatients with mild disease to fatal cases. Our transcriptomic, epigenomic, and proteomic analyses revealed widespread dysfunction of peripheral innate immunity in severe and fatal COVID-19, including prominent hyperactivation signatures in neutrophils and NK cells. We also identified chromatin accessibility changes at NF-κB binding sites within cytokine gene loci as a potential mechanism for the striking lack of pro-inflammatory cytokine production observed in monocytes in severe and fatal COVID-19. We further demonstrated that emergency myelopoiesis is a prominent feature of fatal COVID-19. Collectively, our results reveal disease severity–associated immune phenotypes in COVID-19 and identify pathogenesis-associated pathways that are potential targets for therapeutic intervention.


  • Open Access

    Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19

    by Aaron J. Wilk, Madeline J. Lee, Bei Wei, Benjamin Parks, Ruoxi Pi, Giovanny J. Martinez-Colon, Thanmayi Ranganath, Nancy Q. Zhao, Shalina Taylor, Winston Becker, et al.

    Our understanding of protective vs. pathologic immune responses to SARS-CoV-2, the virus that causes Coronavirus disease 2019 (COVID-19), is limited by inadequate profiling of patients at the extremes of the disease severity spectrum. Here, we performed multi-omic single-cell immune profiling of 64 COVID-19 patients across the full range of disease severity, from outpatients with mild disease to fatal cases. Our transcriptomic, epigenomic, and proteomic analyses reveal widespread dysfunction of peripheral innate immunity in severe and fatal COVID-19, with the most profound disturbances including a prominent neutrophil hyperactivation signature and monocytes with anti-inflammatory features. We further demonstrate that emergency myelopoiesis is a prominent feature of fatal COVID-19. Collectively, our results reveal disease severity-associated immune phenotypes in COVID-19 and identify pathogenesis-associated pathways that are potential targets for therapeutic intervention. One Sentence Summary: Single-cell profiling demonstrates multifarious dysregulation of innate immune phenotype associated with COVID-19 severity.